Free Trial

China SXT Pharmaceuticals (SXTC) SEC Filings & 10K Form

China SXT Pharmaceuticals logo
$2.78 +0.06 (+2.21%)
Closing price 03/28/2025 03:59 PM Eastern
Extended Trading
$2.77 -0.01 (-0.36%)
As of 03/28/2025 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent China SXT Pharmaceuticals SEC Filings

DateFilerForm TypeView
03/28/2025
1:17 PM
China SXT Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/28/2025
6:21 AM
China SXT Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2025
7:36 AM
China SXT Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/27/2025
3:00 PM
China SXT Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/23/2025
3:15 PM
China SXT Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2025
12:01 PM
China SXT Pharmaceuticals (Subject)
Streeterville Capital LLC (Filed by)
Form SCHEDULE 13G/A
11/04/2024
11:15 PM
China SXT Pharmaceuticals (Filer)
Form EFFECT
10/25/2024
11:19 AM
China SXT Pharmaceuticals (Subject)
Streeterville Capital LLC (Filed by)
Form SC 13G/A
10/22/2024
3:51 PM
China SXT Pharmaceuticals (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
10/15/2024
3:15 PM
China SXT Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
8:45 AM
China SXT Pharmaceuticals (Subject)
Forsakringsaktiebolaget Avanza Pension (Filed by)
Form SC 13G/A
08/13/2024
3:15 PM
China SXT Pharmaceuticals (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
07/31/2024
3:15 PM
China SXT Pharmaceuticals (Filer)
Form NT 20-F
05/31/2024
9:36 AM
China SXT Pharmaceuticals (Subject)
Forsakringsaktiebolaget Avanza Pension (Filed by)
Form SC 13G/A
04/05/2024
8:25 AM
China SXT Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:SXTC) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners